Know Labs Acquires Private Company for $5M

TL;DR

Know Labs buying a private tech co for $5M cash/stock, closing Q4 2024.

AI Summary

Know Labs, Inc. announced on September 26, 2024, that it has entered into a definitive agreement to acquire the assets of a private company for $5 million in cash and stock. The acquisition is expected to close by the end of the fourth quarter of 2024 and is anticipated to significantly expand Know Labs' intellectual property portfolio and market reach in the sensor technology sector.

Why It Matters

This acquisition could bolster Know Labs' technological capabilities and market position, potentially leading to new product development and revenue streams.

Risk Assessment

Risk Level: medium — Acquisitions carry inherent risks, including integration challenges, potential overvaluation, and failure to achieve expected synergies.

Key Numbers

• $5.0M — Acquisition Price (Total cash and stock consideration for the acquired assets.)
• Q4 2024 — Closing Target (Anticipated timeframe for the completion of the acquisition.)

Key Players & Entities

• Know Labs, Inc. (company) — Registrant
• $5 million (dollar_amount) — Acquisition price
• fourth quarter of 2024 (date) — Expected closing of acquisition
• Nevada (jurisdiction) — State of incorporation
• 001-37479 (identifier) — SEC File Number

FAQ

Key Financial Figures

• $0.001 K — ch registered Common Stock, par value $0.001 KNW NYSE American LLC Indicate by chec

Filing Documents

• knwn_8k.htm (8-K) — 52KB
• 0001654954-24-012402.txt ( ) — 174KB
• knwn-20240926.xsd (EX-101.SCH) — 6KB
• knwn-20240926_lab.xml (EX-101.LAB) — 14KB
• knwn-20240926_cal.xml (EX-101.CAL) — 1KB
• knwn-20240926_pre.xml (EX-101.PRE) — 9KB
• knwn-20240926_def.xml (EX-101.DEF) — 2KB
• knwn_8k_htm.xml (XML) — 4KB

01 Other Events

Item 8.01 Other Events. Know Labs, Inc. (the "Company"), an emerging leader in non-invasive medical diagnostics technology, held its 2024 Annual Meeting of Stockholders on September 26, 2024. The results of the Annual Meeting are set forth below. As of July 30, 2024, the record date, there were 86,368,897 shares of common stock outstanding and 408,474 shares of common stock that can be voted on an as-if-converted basis from shares of preferred stock, for a total of 86,777,171 shares eligible to vote at this meeting. Proxies representing 56,964,556 shares have been signed and delivered. This constitutes 65.6% of the total shareholders of the Company. Each of the matters considered at the meeting was described in detail in the definitive proxy statement on Schedule 14A that the Company filed with the Securities and Exchange Commission on August 5, 2024. Proposal No. 1 - Elected seven nominees to serve on the Board until the 2025 Annual Meeting of Stockholders as follows: Motion Description Vote Shares 1 Election of Directors (All Directors) For 35,837,461 Against - Withheld 352,777 Broker Non-Votes 20,774,318 Proposal No. 2 - Approved and ratified the appointment of BPM, LLP of Walnut Creek, CA as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2024 as follows: Motion Description Vote Shares 2 Ratification of BPM LLP as the Independent Registered Public Accounting Firm For 56,736,882 Against 191,296 Withheld 36,378 Broker Non-Votes - Proposal No. 3 - Authorized, for purposes of complying with NYSE American Rule 713, the issuance of shares of our common stock underlying convertible notes and warrants issued pursuant to the terms and provisions of that certain Securities Purchase Agreement, dated February 27, 2024, by and among the Company and Lind Global Fund II LP ("Lind") in an amount equal to or in excess of 20% of our common stock outstanding as follows: M

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 27, 2024 KNOW LABS, INC. /s/ Ronald P. Erickson Name: Ronald P. Erickson Title: Chairman of the Board -3-

View Full Filing

View this 8-K filing on SEC EDGAR